MariMed Inc. (MRMD) Financial Statements (2025 and earlier)

Company Profile

Business Address 10 OCEANA WAY
NORWOOD, MA 02062
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,28214,7339,86029,9344,3562,188
Cash and cash equivalent7,28214,6459,73729,6832,999739
Short-term investments  881232511,3571,449
Receivables8,7947,3566,8231,9207,9922,291
Inventory, net of allowances, customer advances and progress billings33,48825,30619,4779,7686,8311,219
Inventory33,48825,30619,4779,7686,8311,219
Other current assets3,3893,4077,2821,441583192
Other undisclosed current assets 5566307041,5511,2821,486
Total current assets:53,50951,43244,14644,61321,0437,377
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization4,0733,2957134678111
Operating lease, right-of-use asset8,7309,7164,9315,0815,2475,787
Property, plant and equipment94,16789,10371,64162,15045,63742,792
Long-term investments and receivables8401,0357,4678,9872,1312,964
Long-term investments  221  1,1661,325
Accounts and financing receivable, after allowance for credit loss8408147,4678,9879651,639
Intangible assets, net (including goodwill)34,45129,00522,2802,2302,2292,364
Goodwill15,81211,9938,079   
Intangible assets, net (excluding goodwill)18,63917,01214,2012,2302,2292,364
Other noncurrent assets11,21912,5371,0249880176
Total noncurrent assets:153,480144,691108,05678,59255,40254,195
TOTAL ASSETS:206,989196,123152,202123,20576,44561,572
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17,62412,5509,71724,7128,66610,115
Taxes payable18,265  
Accounts payable13,1899,0016,6265,0995,0454,719
Accrued liabilities4,4353,5493,0911,3493,6215,396
Debt7,1441,9334,011378,89824,069
Other liabilities    21,077858
Due to related parties  1,1581,455
Other undisclosed current liabilities23,91016,37912,7622,4713,428224
Total current liabilities:48,67830,86226,49027,22323,22736,720
Noncurrent Liabilities
Long-term debt and lease obligation1,9262,14026,4045,04515,5495,475
Long-term debt, excluding current maturities   25,94344810,682 
Finance lease, liability1,9262,140461224475
Liabilities, other than long-term debt7,6498,5554,273100100100
Other liabilities100100100100100100
Operating lease, liability7,5498,4554,1734,5744,8225,399
Other undisclosed noncurrent liabilities69,86065,652 16,81314,74412,948
Total noncurrent liabilities:79,43576,34730,67721,95830,39318,523
Total liabilities:128,113107,20957,16749,18153,62055,244
Temporary equity, including noncontrolling interest19,00019,00037,72537,72514,725 
Equity
Equity, attributable to parent61,62871,56458,78237,8628,6674,546
Common stock381375341334314228
Common stock, share subscribed but unissued, subscriptions receivable     (5)(1,168)
Additional paid in capital173,366171,144142,365134,920112,974112,246
Accumulated deficit(112,119)(99,955)(83,924)(97,392)(104,617)(106,761)
Equity, attributable to noncontrolling interest(1,752)(1,650)(1,511)(1,563)(577)(553)
Other undisclosed equity   39 112,336
Total equity:59,87669,91457,31036,2998,1006,328
TOTAL LIABILITIES AND EQUITY:206,989196,123152,202123,20576,44561,572

Income Statement (P&L) ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues157,964148,598134,010121,46450,89545,605
Operating lease, lease income1,1001,7873,52618,70013,900 
Revenue from related parties   29,029
Cost of revenue(95,096)(82,679)(70,053)(55,201)(19,570)(26,903)
Gross profit:62,86865,91963,95766,26331,32518,702
Operating expenses(59,956)(51,534)(43,588)(39,400)(16,794)(60,300)
Operating income (loss):2,91214,38520,36926,86314,531(41,598)
Nonoperating expense(6,880)(20,981)(861)(3,048)(10,034)(40,283)
Investment income, nonoperating    (1,107)  
Interest and debt expense(6,944)(10,431)(1,693)(2,356)(45)(5)
Income (loss) from continuing operations before equity method investments, income taxes:(10,912)(17,027)17,81521,4604,452(81,886)
Other undisclosed income from continuing operations before income taxes6,94410,4311,6932,35645 
Income (loss) from continuing operations before income taxes:(3,968)(6,596)19,50823,8164,496(81,886)
Income tax expense(8,159)(9,411)(5,894)(16,192)(2,067) 
Income (loss) from continuing operations:(12,127)(16,007)13,6147,6242,429(81,886)
Income (loss) before gain (loss) on sale of properties:7,6242,429(81,886)
Other undisclosed net income      5
Net income (loss):(12,127)(16,007)13,6147,6242,429(81,881)
Net income (loss) attributable to noncontrolling interest(37)(24)(146)(399)(285)696
Net income (loss) available to common stockholders, diluted:(12,164)(16,031)13,4687,2252,144(81,185)

Comprehensive Income ($ in thousands)

3/31/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(12,127)(16,007)13,6147,6242,429(81,881)
Comprehensive income (loss):(12,127)(16,007)13,6147,6242,429(81,881)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(37)(24)(146)(399)(285)696
Comprehensive income (loss), net of tax, attributable to parent:(12,164)(16,031)13,4687,2252,144(81,185)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: